Review
Open access
Sep 2026
Bortezomib‐based chemotherapy in Chinese pediatric patients with relapsed/refractory acute lymphoblastic leukemia: A single‐center retrospective study
ABSTRACT Importance Relapsed/refractory acute lymphoblastic leukemia (R/R ALL) remains a major challenge in pediatric hematologic malignancies, with poor outcomes following standard salvage therapy. Real‐world data regarding the use of bortezomib‐based regimens in Chinese children are limited. Objective To evaluate the...
Xing-Yu Zhao, Jian Wang, Li-Ping Que et al.
· Pediatric Investigation · 0 citations